Establishing the Median Infectious Dose (ID50) and Characterizing the Clinical Manifestations of Mouse, Rat, Cow, and Human Corynebacterium bovis Isolates in Select Immunocompromised Mouse Strains
G. Mendoza, C. Cheleuitte-Nieves, N. S. Lipman…·R. J. Ricart Arbona
This study determines the ID50 and clinical manifestations of Cb isolates from mice, rats, cows, and humans in immunocompromised mice, showing differences in infectivity and disease severity.